Mark Andrew White
Insider Reports History
- Location
- Cranbury, NJ
- Signature
- /s/ Martin Wilson, as attorney-in-fact for Mark Andrew White
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Mark Andrew White:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | General Manager, Commercial Affairs | Common Stock | 69,140 | $1,149,453 | $16.62 | 31 Oct 2024 | Direct |
| ROCKET PHARMACEUTICALS, INC. | General Manager, Commercial Affairs | Stock Option (Right to Buy) | 32,727 | $410,724 | $12.55 | 16 Feb 2024 | Direct |
Insider Reports Filed by Mark Andrew White
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | 31 Oct 2024 | 1 | -$51,205 | 4 | General Manager, Commercial Affairs | 04 Nov 2024, 16:06 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 08 Jul 2024 | 1 | -$61,715 | 4 | General Manager, Commercial Affairs | 09 Jul 2024, 16:05 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 08 Apr 2024 | 1 | -$308,763 | 4 | General Manager, Commercial Affairs | 10 Apr 2024, 20:39 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 16 Feb 2024 | 2 | $0 | 4 | Chief Medical Officer | 21 Feb 2024, 20:54 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 04 Apr 2023 | 2 | $0 | 4 | Chief Medical Officer | 12 Apr 2023, 19:00 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 04 Apr 2023 | 0 | $0 | 3 | Chief Medical Officer | 12 Apr 2023, 18:47 |